In addition, side effects such as anxiety and depression were observed in two individuals with DAA treatments in combination with RBV or PEG-IFN (SOF/RBV/PEG-IFN, DSV/OBV/PTV/RTV/RBV). This evidence concerns the gene IFNA1 and depressive disorder.